Carbohydrate Metabolism

Pipeline Programs

Companies

Clinical Trials

Approved Products

Pipeline by Development Stage

Preclinical

Phase 1

Phase 1/2

Phase 2

Phase 2/3

Phase 3

On Market

Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Pre

P1/2

P2/3

Mkt

AbbottABBOTT PARK, IL

1 program

ControlN/A3 trials

Active Trials

NCT07835685Not Yet Recruiting220Est. Apr 2028

NCT03185884Completed20Est. Aug 2017

NCT00735787Completed81Est. Sep 2009

Trial Timeline

Clinical trial activity over time

2021

2022

2023

2024

2025

2026

2027

2028

AbbottControl

Clinical Trials (3)

Total enrollment: 321 patients across 3 trials

NCT00735787 AbbottControl

Controlled Study of Humira in Subjects With Chronic Plaque Psoriasis of the Hands and/or Feet

Start: Aug 2008Est. completion: Sep 200981 patients

Phase 4Completed

NCT07835685 AbbottControl

Glycemic Control and Quality of Life Evolution for Patients With T1D Using the myLoop Powered by CamAPS FX System in Combination With FreeStyle Libre 3 / 3 Plus Sensors in France

Start: Oct 2026Est. completion: Apr 2028220 patients

N/ANot Yet Recruiting

NCT03185884 AbbottControl

Carbohydrates and Children

Start: Jul 2017Est. completion: Aug 201720 patients

N/ACompleted

Phase Legend

Preclinical— Lab & animal studies

Phase 1— Safety & dosing

Phase 2— Efficacy testing

Phase 3— Large-scale trials

On Market— Approved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.